58096 Federal Register / Vol. 65, No. 188 / Wednesday, September 27, 2000 / Notices

Agenda: To review and evaluate grant

applications.

Place: Arlington Hyatt, 1325 Wilson

Boulevard, Arlington, VA 22209.

Contact Person: Khursheed Asghar, Chief,

Basic Sciences Review Branch, Office of

Extramural Affairs, National Institute on

Drug Abuse, National Institutes of Health,

6001 Executive Boulevard, Room 3158, MSC

9547, Bethesda, MD 20892–9547, (301) 443–

2620.

Name of Committee: National Institute on

Drug Abuse Special Emphasis Panel,

Cognitive Approaches to Addictive

Processes.

Date: November 14–15, 2000.

Time: 8:30 a.m. to 5 p.m.

Agenda: To review and evaluate grant

applications.

Place: Radisson Barcelo Hotel, 2121 P

Street, NW., Washington, DC 20037.

Contact Person: Marina. L. Volkov, Health

Scientist Administrator, Office of Extramural

Program Review, National Institute on Drug

Abuse, National Institutes of Health, DHHS,

6001 Executive Boulevard, Room 3158, MSC

9547, Bethesda, MD 20892–9547, (301) 435–

1433.

Name of Committee: National Institute on

Drug Abuse Initial Review Group, Training

and Career Development Subcommittee.

Date: November 14–16, 2000.

Time: 9:00 a.m. to 5 p.m.

Agenda: To review and evaluate grant

applications.

Place: Arlington Hyatt, 1325 Wilson

Boulevard, Arlington, VA 22209.

Contact Person: Mark Swieter, Health

Scientist Administrator, Office of Extramural

Affairs, National Institute on Drug Abuse,

National Institutes of Health, DHHS, 6001

Executive Boulevard, Room 3158, MSC 9547,

Bethesda, MD 20892–9547, (301) 435–1389.

Name of Committee: National Institute on

Drug Abuse Special Emphasis Panel,

Training and Career Development.

Date: November 16, 2000.

Time: 3:00 p.m. to 6 p.m.

Agenda: To review and evaluate grant

applications.

Place: Arlington Hyatt, 1325 Wilson

Boulevard, Arlington, VA 22209.

Contact Person: Rita Liu, Health Scientist

Administrator, Office of Extramural Affairs,

National Institute on Drug Abuse, National

Institutes of Health, DHHS, 6001 Executive

Boulevard, Room 3158, MSC 9547, Bethesda,

MD 20892–9547, (301) 443–2620.

Name of Committee: National Institute on

Drug Abuse Special Emphasis Panel, Centers

Review Committee.

Date: November 20–21, 2000.

Time: 8:30 a.m. to 12 p.m.

Agenda: To review and evaluate grant

applications.

Place: Ritz-Carlton Hotel at Pentagon City,

1250 South Hayes Street, Arlington, VA

22202.

Contact Person: Rita Liu, Health Scientist

Administrator, Office of Extramural Affairs,

National Institute on Drug Abuse, National

Institutes of Health, DHHS, 6001 Executive

Boulevard, Room 3158, MSC 9547, Bethesda,

MD 20892–9547, (301) 443–2620.

Name of Committee: National Institute on

Drug Abuse Special Emphasis Panel,

Genetics and Consequences of Nicotine

Addiction.

Date: November 21, 2000.

Time: 1 p.m. to 5 p.m.

Agenda: To review and evaluate grant

applications.

Place: Ritz-Carlton Hotel at Pentagon City,

1250 South Hayes Street, Arlington, VA

22202.

Contact Person: Rita Liu, Health Scientist

Administrator, Office of Extramural Affairs,

National Institute on Drug Abuse, National

Institutes of Health, DHHS, 6001 Executive

Boulevard, Room 3158, MSC 9547, Bethesda,

MD 20892–9547, (301) 443–2620.

(Catalogue of Federal Domestic Assistance

Program Nos. 93.277, Drug Abuse Scientist

Development Award for Clinicians, Scientist

Development Awards, and Research Scientist

Awards; 93.278, Drug Abuse National

Research Service Awards for Research

Training; 93.279, Drug Abuse Research

Programs, National Institutes of Health, HHS)

Dated: September 19, 2000.

LaVerne Y. Stringfield,

Director, Office of Federal Advisory

Committee Policy.

[FR Doc. 00–24722 Filed 9–26–00; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

National Institutes of Dental &

Craniofacial Research; Notice of

Closed Meetings

Pursuant to section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of the following

meetings.

The meetings will be closed to the

public in accordance with the

provisions set forth in sections

552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,

as amended. The grant applications and

the discussions could disclose

confidential trade secrets or commercial

property such as patentable material,

and personal information concerning

individuals associated with the grant

applications, the disclosure of which

would constitute a clearly unwarranted

invasion of personal privacy.

Name of Committee: National Institute of

Dental and Craniofacial Research Special

Emphasis Panel, C–01, NIST Site Visit.

Date: October 1–2, 2000.

Time: 8:30 a.m. to 5 p.m.

Agenda: To review and evaluate

cooperative agreement applications.

Place: National Institute of Standards and

Technology, Quince Orchard Road,

Gaithersburg, MD 20899.

Contact Person: Anna Sandberg, Scientific

Review Administrator, National Institute of

Dental & Craniofacial Res., 45 Center Drive,

Natcher Building, Rm. 4AN44F, Bethesda,

MD 20892, (301) 594–3089.

This notice is being published less than 15

days prior to the meeting due to the timing

limitations imposed by the review and

funding cycle.

Name of Committee: National Institute of

Dental and Craniofacial Research Special

Emphasis Panel, 01–01, Review of P01–

Applicant Interview.

Date: October 12–13, 2000.

Time: 7 a.m. to 5 p.m.

Agenda: To review and evaluate grant

applications.

Place: Marriott Pooks Hill, 5151 Pooks Hill

Road, Bethesda, MD 20814.

Contact Person: Yasaman Shirazi,

Scientific Review Administrator, 4500 Center

Drive, Natcher Building, Rm. 4AN44F,

National Institute of Dental & Craniofacial

Res., Bethesda, MD 20892, (301) 594–2372.

Name of Committee: National Institute of

Dental and Craniofacial Research Special

Emphasis Panel, 01–02, Review of F, K, and

R03 Grants.

Date: October 19–20, 2000.

Time: 8 a.m. to 5 p.m.

Agenda: To review and evaluate grant

applications.

Place: Bethesda Marriott, 5151 Pooks Hill

Road, Bethesda, MD 20892.

Contact Person: William J. Gartland,

Scientific Review Administrator, Scientific

Review Section, National Institute of Dental

Research, National Institutes of Health, PHS,

DHHS, Bethesda, MD 20892, (301) 594–2372.

Name of Committee: National Institute of

Dental and Craniofacial Research Special

Emphasis Panel, 01–06, Review of R21

Grants.

Date: October 23–24, 2000.

Time: 8:30 a.m. to 5 p.m.

Agenda: To review and evaluate grant

applications.

Place: Ramada Inn Rockville, 1775

Rockville Pike, Rockville, MD 20852.

Contact Person: Anna Sandberg, Scientific

Review Administrator, National Institute of

Dental & Craniofacial Res., 45 Center Drive,

Natcher Building, Rm. 4AN44F, Bethesda,

MD 20892, (301) 594–3089.

Name of Committee: National Institute of

Dental and Craniofacial Research Special

Emphasis Panel, 01–10, Review of R44

Grants.

Date: October 31, 2000.

Time: 11 a.m. to 12:30 p.m.

Agenda: To review and evaluate grant

applications.

Place: 45 Natcher Bldg., Rm 5As.25u,

Bethesda, MD 20892, (Telephone Conference

Call).

Contact Person: Philip Washko, Scientific

Review Administrator, 45 Center Drive,

Natcher Building, Rm. 4AN44F, National

Institutes of Health, Bethesda, MD 20892,

(301) 594–2372.

Name of Committee: National Institute of

Dental and Craniofacial Research Special

Emphasis Panel, 01–07, Review of RFA–HIV/

AIDS.

Date: November 2, 2000.

Time: 8:30 a.m. to 5 p.m.

Agenda: To review and evaluate grant

applications.

Place: George Washington University Inn,

824 New Hampshire Ave, NW, Washington,

DC 20037.

Federal Register / Vol. 65, No. 188 / Wednesday, September 27, 2000 / Notices 58097

Contact Person: Yasaman Shirazi,

Scientific Review Administrator, 4500 Center

Drive, Natcher Building, Rm. 4AN44F,

National Institute of Dental & Craniofacial

Res., Bethesda, MD 20892, (301) 594–2372.

Name of Committee: National Institute of

Dental and Craniofacial Research Special

Emphasis Panel, 01–05, Review of R44

Grants.

Date: November 14, 2000.

Time: 1 p.m. to 3 p.m.

Agenda: To review and evaluate grant

applications.

Place: 45 Natcher Bldg., Rm 5As.25u,

Bethesda, MD 20892, (Telephone Conference

Call).

Contact Person: Philip Washko, Scientific

Review Administrator, 45 Center Drive,

Natcher Building, Rm. 4AN44F, National

Institutes of Health, Bethesda, MD 20892,

(301) 594–2372.

Name of Committee: National Institute of

Dental and Craniofacial Research Special

Emphasis Panel, 01–09, Review of R01

Grants.

Date: November 16, 2000.

Time: 1 p.m. to 2 p.m.

Agenda: To review and evaluate grant

applications.

Place: Natcher Building, Rm. 4AN44F,

Bethesda, MD 20892, (Telephone Conference

Call).

Contact Person: Philip Washko, Scientific

Review Administrator, 45 Center Drive,

Natcher Building, Rm. 4AN44F, National

Institutes of Health, Bethesda, MD 20892,

(301) 594–2372.

Name of Committee: National Institute of

Dental and Craniofacial Research Special

Emphasis Panel, 01–04, Review of R44

Grants.

Date: November 22, 2000.

Time: 10 a.m. to 12 p.m.

Agenda: To review and evaluate grant

applications.

Place: 45 Center Drive, Bethesda, MD

20892, (Telephone Conference Call).

Contact Person: Philip Washko, Scientific

Review Administrator, 45 Center Drive,

Natcher Building, Rm. 4AN44F, National

Institutes of Health, Bethesda, MD 20892,

(301) 594–2372.

(Catalogue of Federal Domestic Assistance

Program Nos. 93.121, Oral Diseases and

Disorders Research, National Institutes of

Health, HHS)

Dated: September 19, 2000.

LaVerne Y. Stringfield,

Director, Office of Federal Advisory

Committee Policy.

[FR Doc. 00–24723 Filed 9–26–00; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

National Institute on Drug Abuse;

Notice of Closed Meeting

Pursuant to section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of a meeting of the

Board of Scientific Counselors, NIDA.

The meeting will be closed to the

public as indicated below in accordance

with the provisions set forth in section

552b(c)(6), Title 5 U.S.C., as amended

for the review, discussion, and

evaluation of individual intramural

programs and projects conducted by the

National Institute on Drug Abuse,

including consideration of personnel

qualifications and performance, and the

competence of individual investigators,

the disclosure of which would

constitute a clearly unwarranted

invasion of personal privacy.

Name of Committee: Board of Scientific

Counselors, NIDA.

Date: October 17–19, 2000.

Time: 1 p.m. to 12 p.m.

Agenda: To review and evaluate personal

qualifications and performance, and

competence of individual investigators.

Place: Intramural Research Program,

National Institute on Drug Abuse, Johns

Hopkins Bayview Campus, Bldg. C, 2nd

Floor Auditorium, 5500 Nathan Shock Drive,

Baltimore, MD 21224.

Contact Person: Stephen J. Heishman,

Research Psychologist, Clinical

Pharmacology Branch, Addiction Research

Center, National Institute on Drug Abuse,

National Institutes of Health, DHHS, 5500

Nathan Shock Drive, Baltimore, MD 21224,

(410) 550–1547.

(Catalogue of Federal Domestic Assistance

Program Nos. 93.277, Drug Abuse Scientist

Development Award for Clinicians, Scientist

Development Awards, and Research Scientist

Awards; 93.278, Drug Abuse National

Research Service Awards for Research

Training; 93.279, Drug Abuse Research

Programs, National Institutes of Health, HHS)

Dated: September 19, 2000.

LaVerne Y. Stringfield,

Director, Office of Federal Advisory

Committee Policy.

[FR Doc. 00–24724 Filed 9–26–00; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

National Institute of Child Health and

Human Development; Notice of Closed

Meeting

Pursuant to section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of the following

meeting.

The meeting will be closed to the

public in accordance with the

provisions set forth in section 552b(c)(4)

and 552b(c)(6), Title 5 U.S.C., as

amended. The grant applications and

the discussions could disclose

confidential trade secrets or commercial

property such as patentable material,

and personal information concerning

individuals associated with the grant

applications, the disclosure of which

would constitute a clearly unwarranted

invasion of personal privacy.

Name of Committee: National Institute of

Child Health and Human Development Initial

Review Group, Population Research

Subcommittee.

Date: October 23–24, 2000.

Time: 8 a.m. to 12 p.m.

Agenda: To review and evaluate grant

applications.

Place: Chevy Chase Holiday Inn, 5520

Wisconsin Avenue, Chevy Chase, MD 20815.

Contact Person: Jon M. Ranhand, Health

Scientist Administrator, Division of

Scientific Review, National Institute of Child,

Health and Human Development, 6100

Executive Blvd., Rm. 5E01, MSC 7510,

Bethesda, MD 20892, (301) 435–6884.

(Catalogue of Federal Domestic Assistance

Program Nos. 93.209, Contraception and

Infertility Loan Repayment Program; 93.864,

Population Research; 93.865, Research for

Mothers and Children; 93.929, Center for

Medical Rehabilitation Research, National

Institutes of Health, HHS)

Dated: September 19, 2000.

LaVerne Y. Stringfield,

Director, Office of Federal Advisory

Committee Policy.

[FR Doc. 00–24729 Filed 9–26–00; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Public Health Service

National Institute of Environmental

Health Sciences, NIH; National

Toxicology Program; Peer Review

Meeting on Low-Dose Issues for

Endocrine Disruptors; Update on

Meeting Scope; Meeting Agenda; and

Registration Information

Summary

The National Toxicology Program

(NTP) is organizing a Peer Review to

evaluate dose-response relationships for

endocrine disrupting chemicals. In

particular, the panel will evaluate

whether chemicals can cause hormonerelated effects at doses lower than those

typically used in the standard

toxicological dose-setting paradigm. The

U.S. Environmental Protection Agency

(EPA) Endocrine Disruptor Screening

Program will use the results from this

peer review to assist in determining

how to identify and characterize

potential low-dose effects that may arise

during endocrine disruptor screening,

testing, and hazard assessment. If the